(19)
(11) EP 3 764 815 A1

(12)

(43) Date of publication:
20.01.2021 Bulletin 2021/03

(21) Application number: 19767008.6

(22) Date of filing: 15.03.2019
(51) International Patent Classification (IPC): 
A23L 27/30(2016.01)
C07H 15/256(2006.01)
A23L 2/60(2006.01)
(86) International application number:
PCT/US2019/022456
(87) International publication number:
WO 2019/178471 (19.09.2019 Gazette 2019/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 16.03.2018 US 201862644065 P
17.03.2018 US 201862644407 P
10.04.2018 WO PCT/US2018/026920
08.06.2018 US 201862682461 P
27.11.2018 US 201862771937 P
15.02.2019 US 201962806646 P

(71) Applicant: PureCircle USA Inc.
Chicago, IL 60606 (US)

(72) Inventors:
  • MARKOSYAN, Avetik
    Yerevan, 0014 (AM)
  • CHOW, Siew, Yin
    Selangor, 41050 (MY)
  • NIZAM BIN NAWI, Khairul
    Negeri Sembilan, 71950 (MY)
  • CHKHAN, Kristina
    Moscow, 121609 (RU)
  • AFZAAL BIN HASIM, Mohamad
    Kuala Lumpur, 59200 (MY)
  • RAMANDACH, Saravanan, A/l
    Seremban Negeri Sembilan, 70400 (MY)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstrasse 3
81675 München
81675 München (DE)

   


(54) HIGH-PURITY STEVIOL GLYCOSIDES